In vitro transformation of mesenchymal stem cells by oncogenic H-rasVal12
- PMID: 17173860
- DOI: 10.1016/j.bbrc.2006.11.137
In vitro transformation of mesenchymal stem cells by oncogenic H-rasVal12
Abstract
Tissue stem cells may serve as progenitors for malignant tumors derived from the same tissue. Here, we report the establishment of immortalized human mesenchymal stem cells (ihMSC) and tested the feasibility of using ihMSC as presarcomatous cells. Immortalization was achieved by introducing the genes for human telomerase reverse transcriptase and Bmi1. ihMSC retained the potential for multi-directional differentiation of the original MSC. To transform ihMSC, we introduced an oncogenic H-ras(Val12) gene, and established the cell line ihMSC-ras. ihMSC-ras had the phenotype of fully transformed cells and retained adipogenic and chondrogenic, but not osteogenic, potential. Interestingly, ihMSC-ras demonstrated morphological features of autophagy, and inhibition of the ERK pathway suppressed the production of autophagosomes, indicating that ras/ERK signaling is responsible for the induction of autophagy. Thus ihMSC will serve as a material with which to analyze the tumorigenic and differentiation-modifying effects of candidate oncogenes involved in the development of sarcomas.
Similar articles
-
Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.Int J Oncol. 2011 Jul;39(1):5-11. doi: 10.3892/ijo.2011.1029. Epub 2011 May 3. Int J Oncol. 2011. PMID: 21573488
-
In vitro transformation of mesenchymal stem cells induces gradual genomic hypomethylation.Carcinogenesis. 2010 Oct;31(10):1854-62. doi: 10.1093/carcin/bgq080. Epub 2010 May 13. Carcinogenesis. 2010. PMID: 20466760
-
Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.Cancer Res. 2006 Jul 15;66(14):7016-23. doi: 10.1158/0008-5472.CAN-05-3979. Cancer Res. 2006. PMID: 16849546
-
Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis.Epigenomics. 2011 Dec;3(6):715-32. doi: 10.2217/epi.11.93. Epigenomics. 2011. PMID: 22126291 Review.
-
A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.Methods Enzymol. 2006;407:637-47. doi: 10.1016/S0076-6879(05)07050-3. Methods Enzymol. 2006. PMID: 16757358 Review.
Cited by
-
Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells.Neoplasia. 2009 Apr;11(4):397-407. doi: 10.1593/neo.81620. Neoplasia. 2009. PMID: 19308294 Free PMC article.
-
Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression.Exp Hematol Oncol. 2024 Jul 1;13(1):64. doi: 10.1186/s40164-024-00532-4. Exp Hematol Oncol. 2024. PMID: 38951845 Free PMC article. Review.
-
The replicative senescent mesenchymal stem / stromal cells defect in DNA damage response and anti-oxidative capacity.Int J Med Sci. 2018 May 22;15(8):771-781. doi: 10.7150/ijms.24635. eCollection 2018. Int J Med Sci. 2018. PMID: 30008586 Free PMC article.
-
Recent developments in antiviral agents against enterovirus 71 infection.J Biomed Sci. 2014 Feb 12;21(1):14. doi: 10.1186/1423-0127-21-14. J Biomed Sci. 2014. PMID: 24521134 Free PMC article. Review.
-
Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities.Clin Cancer Res. 2024 Nov 1;30(21):4957-4973. doi: 10.1158/1078-0432.CCR-24-1238. Clin Cancer Res. 2024. PMID: 39177582 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous